Jamieson shareholders approve Kirin sale; conditions remain

Jamieson Wellness shareholders have approved the company’s proposed sale to Kirin Holdings, moving the transaction to its remaining court, regulatory and closing steps.

Jamieson said in a September 30 release that 22,384,258 votes, or 70.51% of votes cast, supported the arrangement, while 9,363,984 votes opposed it. In the separate vote excluding holders required by securities rules, support was 70.43%.

The proposed transaction would pay Jamieson shareholders $45.75 in cash for each common share. Shareholder approval does not complete the sale.

The company expects to seek a final court order on October 5. The arrangement also remains subject to regulatory approvals and other customary closing conditions, and the timing could change if those conditions are not met.

Jamieson is a Canadian maker of vitamins, minerals and supplements. Kirin is a Japan-based beverage and health-sciences group. The figures and timetable above are company disclosures, not investment advice.

Illustrative image: Pawel Czerwinski / Unsplash Licence. Cropped and resized; the unlabelled capsules do not depict a Jamieson product.